You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 8, August 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (97)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Attention Deficit Hyperactivity Disorder
 •Randomized Controlled Trial
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, MD; Joseph Biederman, MD; Timothy Wilens, MD; Stephen Faraone, PhD; Jefferson Prince, MD; Kristine Gerard, MD; Robert Doyle, MD; Asha Parekh, MD; Jake Kagan, BA; Sarah Kate Bearman, BA

Arch Gen Psychiatry. 2001;58:775-782.

Background  We report on a controlled trial of a mixed amphetamine salts compound (Adderall, dextroamphetamine sulfate, dextro-, levoamphetamine sulfate, dextroamphetamine aspartate, levoamphetamine aspartate, and dextroamphetamine saccharate) in the treatment of adult attention-deficit/hyperactivity disorder (ADHD).

Methods  This was a 7-week, randomized, double-blind, placebo-controlled, crossover study of Adderall in 27 well-characterized adults satisfying full DSM-IV criteria for ADHD of childhood onset and persistent symptoms into adulthood. Medication was titrated up to 30 mg twice a day. Outcome measures included the ADHD Rating Scale and the Clinical Global Impression Score. Comorbid psychiatric disorders were assessed to test for potential effects on treatment outcome.

Results  Treatment with Adderall at an average oral dose of 54 mg (administered in 2 daily doses) was effective and well tolerated. Drug-specific improvement in ADHD symptoms was highly significant overall (42% decrease on the ADHD Rating Scale, P<.001), and sufficiently robust to be detectable in a parallel groups comparison restricted to the first 3 weeks of the protocol (P<.001). The percentage of subjects who improved (reduction in the ADHD rating scale of >=30%) was significantly higher with Adderall treatment than with a placebo (70% vs 7%; P = .001).

Conclusions  Adderall was effective and well tolerated in the short-term treatment of adults with ADHD. More work is needed to evaluate the long-term effects of Adderall, or other amphetamine compounds, in the treatment of adults with ADHD.


From the Pediatric Psychopharmacology Unit, Massachusetts General Hospital (Drs Spencer, Biederman, Wilens, Faraone, Prince, Gerard, Doyle, and Parekh, Mr Kagan, and Ms Bearman) and the Department of Psychiatry, Harvard Medical School (Drs Spencer, Biederman, Wilens, Faraone, Prince, Gerard, Doyle, and Parekh), Boston.

Reprints: Thomas Spencer, MD, Pediatric Psychopharmacology Unit (ACC-725), Massachusetts General Hospital, Fruit Street, Boston, MA 02114.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Attention-Deficit/Hyperactivity Disorder in Adults: Beyond Controversy
Kenneth D. Gadow and Margaret Weiss
Arch Gen Psychiatry. 2001;58(8):784-785.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modafinil treatment of amphetamine abuse in adult ADHD
Mann and Bitsios
J Psychopharmacol 2009;23:468-471.
ABSTRACT  

Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD
Adler et al.
J Atten Disord 2009;12:449-459.
ABSTRACT  

The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative
de Graaf et al.
Occup. Environ. Med. 2008;65:835-842.
ABSTRACT | FULL TEXT  

The Reliability and Validity of Self- and Investigator Ratings of ADHD in Adults
Adler et al.
J Atten Disord 2008;11:711-719.
ABSTRACT  

Literature Review: ADHD in Adults: A Review of the Literature
Davidson
J Atten Disord 2008;11:628-641.
ABSTRACT  

An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD
Faraone et al.
J Atten Disord 2007;11:157-166.
ABSTRACT  

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Fayyad et al.
Br. J. Psychiatry 2007;190:402-409.
ABSTRACT | FULL TEXT  

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
Nutt et al.
J Psychopharmacol 2007;21:10-41.
ABSTRACT  

The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
Kessler et al.
Am. J. Psychiatry 2006;163:716-723.
ABSTRACT | FULL TEXT  

Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder
Wilens et al.
Arch Pediatr Adolesc Med 2006;160:82-90.
ABSTRACT | FULL TEXT  

Girl, Repeatedly Interrupted: The Case of a Young Adult Woman With ADHD
Ramsay and Rostain
Clinical Case Studies 2005;4:329-346.
ABSTRACT  

Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates
Ricaurte et al.
J. Pharmacol. Exp. Ther. 2005;315:91-98.
ABSTRACT | FULL TEXT  

Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough and Barkley
Am. J. Psychiatry 2004;161:1948-1956.
ABSTRACT | FULL TEXT  

Attention-Deficit/Hyperactivity Disorder in Adults
Wilens et al.
JAMA 2004;292:619-623.
FULL TEXT  

Attention-deficit hyperactivity disorder in adults: validity unknown
Zwi and York
Adv. Psychiatr. Treat. 2004;10:248-256.
ABSTRACT | FULL TEXT  

Attention-Deficit/Hyperactivity Disorder in Adults: A Survey of Current Practice in Psychiatry and Primary Care
Faraone et al.
Arch Intern Med 2004;164:1221-1226.
ABSTRACT | FULL TEXT  

Efficacy of Stimulants in Adult ADHD
Maidment
The Annals of Pharmacotherapy 2003;37:1884-1890.
ABSTRACT | FULL TEXT  

Pharmacological Interventions for Students with ADD
Austin
Intervention in School and Clinic 2003;38:289-296.
ABSTRACT  

Assessment and management of attention-deficit hyperactivity disorder in adults
Weiss and Murray
CMAJ 2003;168:715-722.
ABSTRACT | FULL TEXT  

Other Articles Noted
Evid. Based Ment. Health 2002;5:40-40.
FULL TEXT  

Efficacy of Adderall(R) for Attention-Deficit/Hyperactivity Disorder: A meta-analysis
Faraone and Biederman
J Atten Disord 2002;6:69-75.
ABSTRACT  

Stimulating Improvement for Adult ADHD
JWatch Psychiatry 2001;2001:1-1.
FULL TEXT  

Attention-Deficit/Hyperactivity Disorder in Adults: Beyond Controversy
Gadow and Weiss
Arch Gen Psychiatry 2001;58:784-785.
FULL TEXT  

A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder
Wilens et al.
J Atten Disord 2001;5:189-202.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.